Today announced the filing of a fresh Medication Submission to Wellness Canada.

On July 16 FDA, 2009, BEMA Fentanyl happens to be under regulatory examine in europe with approval expected this year 2010. Under agreements with BDSI, Meda AB gets the worldwide privileges to commercialize and marketplace BEMA Fentanyl, except in South Taiwan and Korea, the privileges to which stay with BDSI.. BioDelivery Sciences International documents NDS for BEMA Fentanyl BioDelivery Sciences International, Inc. today announced the filing of a fresh Medication Submission to Wellness Canada, the regulatory authority in Canada, for BEMA Fentanyl, also referred to as fentanyl buccal soluble film.Stop execution of Medicare reimbursement cuts to malignancy care, especially the payment reduction to cancer drug administration.Stop the 2010 21.2 percent Medicare reimbursement payment cut influencing all physician-related solutions and fix the broken Medicare payment system based on the SGR formula.Prevent cutting cancer treatment reimbursement further through the use of cuts to cover primary care bonuses. Fix the problem of artificially low Medicare drug reimbursement by like the prompt pay option in health care reform legislation.Eliminate the 20 percent Medicare affected person co-payment requirement for cancer drugs. A full statement is shown the organization’s site ( The War on Malignancy, declared almost 40 years ago, has led to increased survival for Us citizens with malignancy and has changed many cancers from a death sentence to a chronic disease, continued Dr.